Product DemonstrationsClinical Diagnostics

Anagnostics’ Drugs of Abuse Screening

29 Apr 2014
Anagnostics’ Drugs of Abuse Screening

Anagnostics’ drugs of abuse screening tests on urine, saliva or serum provide information about the consumption of addictive- or psychotropic substances. Watch this video to see how Anagnostics' drugs of abuse screening test is processed.

About the company

Anagnostics Bioanalysis logo

Anagnostics Bioanalysis

We specialize in developing systems and tests for research and clinical in-vitro diagnostic procedures. Our aim is to provide solutions for unmet needs, especially in the fields of multiplexed protein and nucleic acid analysis.

Since 2005 our ambitious team around molecular geneticist Dr. Bernhard Ronacher develops a new multiplex assay and diagnostics technology. A cylindrical microarray, the patented hybcell, is the core of our technology.

Our vision is to establish hybcell technology in pharmaceutical research and clinical diagnostics.

Some of the benefits of our multiplex technology are the following:

  • Precise, quick and cost-effective results
  • Highly flexible assay design
  • The possibility to measure kinetics
  • Fully automated assay procedure
  • Unprecedented ease of use for microarray assays

Other videos from Anagnostics Bioanalysis

Links

Anagnostics’ Drugs of Abuse Screening